Literature DB >> 23229448

Global trends, potential mechanisms and early detection of organ damage in SLE.

Anselm Mak1, David A Isenberg, Chak-Sing Lau.   

Abstract

Increased longevity of patients with systemic lupus erythematosus (SLE) leads to chronic organ damage accrual, which reduces the possibility of further survival improvement in patients with the disease. Observations from lupus centres worldwide revealed that the prevalence of damage occurring in the cardiovascular system in patients with SLE has increased over the past four decades. The results of a meta-analysis involving over 70 observational studies demonstrated that lupus-related organ damage involving the neuropsychiatric and renal systems also remains a major factor that limits survival improvement in patients with this disease. While efforts to halt acute lupus-related injury are continuing, through early diagnosis and effective use of immunosuppressive agents, a concomitant strategy to improve survival of patients with SLE would be early detection and timely treatment of lupus-related organ damage with meticulous monitoring. This Review discusses the pattern and trend of organ damage in patients with SLE worldwide, the potential serological and genetic mechanisms of organ damage, and the advances in research on potential tools for early detection of lupus-related organ damage, such as functional brain imaging techniques, measurement of endothelial function, identification of biomarkers from body fluids, and development of risk calculation models.

Entities:  

Mesh:

Year:  2012        PMID: 23229448     DOI: 10.1038/nrrheum.2012.208

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN: 1759-4790            Impact factor:   20.543


  99 in total

1.  Urinary vascular cell adhesion molecule, but not neutrophil gelatinase-associated lipocalin, is associated with lupus nephritis.

Authors:  Adnan N Kiani; Tianfu Wu; Hong Fang; Xin J Zhou; Chul W Ahn; Laurence S Magder; Chandra Mohan; Michelle Petri
Journal:  J Rheumatol       Date:  2012-04-15       Impact factor: 4.666

2.  Assessment of bone remodelling in childhood-onset systemic lupus erythematosus.

Authors:  Julie C Baker-LePain; Mary C Nakamura; John Shepherd; Emily von Scheven
Journal:  Rheumatology (Oxford)       Date:  2010-11-23       Impact factor: 7.580

3.  Glutamate receptor biology and its clinical significance in neuropsychiatric systemic lupus erythematosus.

Authors:  Cynthia Aranow; Betty Diamond; Meggan Mackay
Journal:  Rheum Dis Clin North Am       Date:  2010-02       Impact factor: 2.670

4.  Fracture prediction and calibration of a Canadian FRAX® tool: a population-based report from CaMos.

Authors:  L-A Fraser; L Langsetmo; C Berger; G Ioannidis; D Goltzman; J D Adachi; A Papaioannou; R Josse; C S Kovacs; W P Olszynski; T Towheed; D A Hanley; S M Kaiser; J Prior; S Jamal; N Kreiger; J P Brown; H Johansson; A Oden; E McCloskey; J A Kanis; W D Leslie
Journal:  Osteoporos Int       Date:  2010-12-16       Impact factor: 4.507

5.  Autoantibodies closely relate to the elevation level of in vivo hydrogen peroxide and tissue damage in systemic lupus erythematosus.

Authors:  Yongquan Wang; Bin Qiao; Ying Wang; Xiaohui Han; Yiwei Chu; Sidong Xiong
Journal:  DNA Cell Biol       Date:  2006-10       Impact factor: 3.311

6.  Lumbar spine bone mineral density predicts endothelial reactivity in patients with systemic lupus erythematosus.

Authors:  A Mak; Li H Ling; R C M Ho; L Gong; Al A C Cheak; H Yee; S Vasoo; D R Koh; P A Robless
Journal:  Clin Exp Rheumatol       Date:  2011-04-19       Impact factor: 4.473

7.  Antibodies and the Brain: Lessons from Lupus.

Authors:  Betty Diamond
Journal:  J Immunol       Date:  2010-09-01       Impact factor: 5.422

8.  Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients.

Authors:  Ricard Cervera; Munther A Khamashta; Josep Font; Gian Domenico Sebastiani; Antonio Gil; Paz Lavilla; Juan Carlos Mejía; A Olcay Aydintug; Hanna Chwalinska-Sadowska; Enrique de Ramón; Antonio Fernández-Nebro; Mauro Galeazzi; Merete Valen; Alessandro Mathieu; Frédéric Houssiau; Natividad Caro; Paula Alba; Manuel Ramos-Casals; Miguel Ingelmo; Graham R V Hughes
Journal:  Medicine (Baltimore)       Date:  2003-09       Impact factor: 1.889

9.  Autoantibodies to dsDNA cross-react with the arginine-glycine-rich domain of heterogeneous nuclear ribonucleoprotein A2 (hnRNP A2) and promote methylation of hnRNP A2.

Authors:  K-H Sun; S-J Tang; Y-S Wang; W-J Lin; R-I You
Journal:  Rheumatology (Oxford)       Date:  2003-01       Impact factor: 7.580

10.  Pre-procedural atorvastatin mobilizes endothelial progenitor cells: clues to the salutary effects of statins on healing of stented human arteries.

Authors:  Benjamin Hibbert; Xiaoli Ma; Ali Pourdjabbar; Trevor Simard; Katey Rayner; Jiangfeng Sun; Yong-Xiang Chen; Lionel Filion; Edward R O'Brien
Journal:  PLoS One       Date:  2011-01-25       Impact factor: 3.240

View more
  27 in total

1.  Connective tissue diseases: Functional MRI in SLE-the current state.

Authors:  Anselm Mak; Sen Hee Tay
Journal:  Nat Rev Rheumatol       Date:  2015-10-20       Impact factor: 20.543

Review 2.  Orthopedic surgery and its complication in systemic lupus erythematosus.

Authors:  Anselm Mak
Journal:  World J Orthop       Date:  2014-01-18

Review 3.  The pathogenesis and diagnosis of systemic lupus erythematosus: still not resolved.

Authors:  Ole Petter Rekvig; Johan Van der Vlag
Journal:  Semin Immunopathol       Date:  2014-04-25       Impact factor: 9.623

Review 4.  Treat to target in systemic lupus erythematosus: a commentary.

Authors:  Manuel F Ugarte-Gil; Paula I Burgos; Graciela S Alarcón
Journal:  Clin Rheumatol       Date:  2016-07-12       Impact factor: 2.980

5.  Cortical thinning and progressive cortical porosity in female patients with systemic lupus erythematosus on long-term glucocorticoids: a 2-year case-control study.

Authors:  T Y Zhu; J F Griffith; L Qin; V W Y Hung; T-N Fong; S-K Au; X-L Tang; E W Kun; A W Kwok; P-C Leung; E K Li; L-S Tam
Journal:  Osteoporos Int       Date:  2015-03-04       Impact factor: 4.507

6.  Carbon monoxide inhibits T cell activation in target organs during systemic lupus erythematosus.

Authors:  J P Mackern-Oberti; J Obreque; G P Méndez; C Llanos; A M Kalergis
Journal:  Clin Exp Immunol       Date:  2015-07-07       Impact factor: 4.330

Review 7.  Toll-like receptor-mediated immune responses in intestinal macrophages; implications for mucosal immunity and autoimmune diseases.

Authors:  Zejun Zhou; Miao Ding; Lei Huang; Gary Gilkeson; Ren Lang; Wei Jiang
Journal:  Clin Immunol       Date:  2016-09-09       Impact factor: 3.969

8.  TLR8 on dendritic cells and TLR9 on B cells restrain TLR7-mediated spontaneous autoimmunity in C57BL/6 mice.

Authors:  Benoit Desnues; Amanda Beatriz Macedo; Annie Roussel-Queval; Johnny Bonnardel; Sandrine Henri; Olivier Demaria; Lena Alexopoulou
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-13       Impact factor: 11.205

9.  Assessment of the risk of low bone mineral density in premenopausal Japanese female patients with systemic lupus erythematosus.

Authors:  Yu Mori; Kazuyoshi Baba; Atsushi Kogure; Takuya Izumiyama; Michiharu Matsuda; Naoko Mori; Tomonori Ishii; Eiji Itoi
Journal:  J Orthop       Date:  2018-01-31

10.  Elevated Interleukin-18 Receptor Accessory Protein Mediates Enhancement in Reactive Oxygen Species Production in Neutrophils of Systemic Lupus Erythematosus Patients.

Authors:  Jie Ma; Ian Kar Yin Lam; Chak-Sing Lau; Vera Sau Fong Chan
Journal:  Cells       Date:  2021-04-21       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.